ArticleFrontiers in genetics2022

Biomarker-driven drug repurposing on biologically similar cancers with DNA-repair deficiencies.

Seeya Awadhut Munj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.